24 neuronal functions related to the 10 genes found in pancreas based on Gene ontology database search. Neuronal processes related to the 10 genes are numbered from 1 to 24 (left side of Figure) and corresponded with numbers 1 to 24 shown in pancreas Figure. Abbreviations are in Table 1 and 2. 

24 neuronal functions related to the 10 genes found in pancreas based on Gene ontology database search. Neuronal processes related to the 10 genes are numbered from 1 to 24 (left side of Figure) and corresponded with numbers 1 to 24 shown in pancreas Figure. Abbreviations are in Table 1 and 2. 

Source publication
Article
Full-text available
Despite numerous developed drugs based on glucose metabolism interventions for treatment of age-related diseases such as diabetes neuropathies (DNs), DNs are still increasing in patients with type 1 or type 2 diabetes (T1D, T2D). We aimed to identify novel candidates in adipose tissue (AT) and pancreas with T2D for targeting to develop new drugs fo...

Context in source publication

Context 1
... homeostasis of blood glucose levels is maintained by both insulin and glucagon synthesis, which is functionally tightly regulated by the pancreatic β-cells and α-cells respectively. When blood glucose levels rise (hyperglycemia), pancreatic β-cells synthesize and secrete insulin to the bloodstream to regulate glucose levels. On the contrary, when circulating glucose levels fall below normal values (hypoglycemia), pancreatic α -cells produce and release glucagon to the bloodstream to tune up glucose concentrations via conversion of stored glycogen into glucose and its release into the circulation [1, 2]. Thus, a disruption in blood glucose regulation leads to the hyperglycemia state so-called diabetes. There are two types of aged-related [3, 4] diabetes; type 1 diabetes (T1D) and type 2 diabetes (T2D). Diminished or dysregulation of insulin by β-cells in T1D and T2D respectively are caused by cell aging process. T1D is an autoimmune disease that pancreatic β-cells are targeted to be broken down by antibodies produced by immune B cells. In this regard, the main production site of insulin is diminished by β-cells [5–9]. In contrast, in age-related-T2D the pancreatic β-cells are still active and do synthesize insulin but at dysregulated levels and not sensitive enough [10–13]. In a normal state, there is a homeostatic balance and cross talk between skeletal muscle, liver and adipose tissue (AT) organs with respect to glucose levels, which is strictly under control of insulin [14]. In this regard, insulin 1- promotes glucose uptake and inhibits lipolysis by the skeletal muscle, 2- stimulates glycogenesis and suppress glucose formation and release from the liver, and 3- stimulates adipogenesis and prevent lipolysis in AT-associated adipocytes [14]. In an obese state, insulin shows a function completely opposite to the normal state in these three organs. Moreover, it has been recently shown that other cells such as adipocytes, macrophages also synthesize insulin [15]. Patients with either T1D or T2D diabetes are at high risk for serious complications such as cardiovascular diseases (CVDs) [16] and diabetic neuropathy (DN) [17–23]. Obesity plays an important role in the development of T2D and its complications via the promotion of an inflammatory state [16]. In this regard, Systems biology could be a solution to find etiology of aged-related diseases such as T1D, T2D, neurodegenerative and cardiovascular diseases [24]. DNs are the most common micro-vascular complications that occur in both T1 and T2 diabetes (40–60%) [18–20, 25, 26]. DNs-associated syndromes are classified into two groups; diffuse and focal. The former neuropathies are usually chronic and more common among diabetic patients, while focal neuropathies are acute [25]. In general, DNs occur in progressive damages of neuronal cells that commonly appear with symptoms such as severe pain, loss of sensation and disability [19, 22, 25]. Despite the general agreement that hyperglycemia plays a key role in initiation and development of DNs, the underlying mechanisms for the development of DNs is unknown and remains to be investigated [19, 22, 27]. Numerous studies have shown that hyperglycemia leads to the overload of electron transport chain in mitochondria and subsequent oxidative stress. The imbalance in the mitochondrial redox state, in favor of oxidation conditions, leads to the accumulation of reactive oxygen species (ROS). Subsequently, oxidative stress affects several metabolic pathways [such as insulin signaling pathway and protein kinase C (PKC) pathway; advanced glycation end products (AGEs) and mitogen activated protein kinase (MAPKs)] associated with glucose metabolism with enhanced oxidative stress and, in turn, inflammatory reactions [20, 21, 25, 28–32]. Although numerous drugs and therapies have been proposed to treat the DNs, the majority of these drugs and treatments were restricted to target the redox and glucose metabolic pathways [20, 32]. None of the drugs that targeted glucose metabolic pathways showed any efficient effect in the treatment of DNs [19, 22]. Also, despite identification of the genes [19] and metabolic pathways associated with DNs, the molecular causes of DNs events still occur in a large scale. These studies suggest that beside hyperglycemia other genetic components and factors may contribute to the development of DNs. For instance, tight links between oxidative stress and obesity were recently reported, which may provide new insight for investigation of the genes associated with DNs [21]. Meijer et al. have recently shown that metabolic dysfunction leads to the adipocytes hypertrophy (the main cause of obesity), which primes inflammation in AT [15, 16] and, in turn, is implicated in pathophysiological states such as energy storage disruption within adipocytes (e.g. triglycerides breakdown, FFAs, glycerol et cetera), insulin resistance (IR), and hyperglycemia as hallmark of T2D. Feldman et al . reported several pathways involved in lipid, carbohydrate and energy metabolism modulating gene expression patterns in peripheral nerves on BKS db/ db mouse sciatic nerve. Although this study support the hypothesis that hyperglycemia play an important role in nerve damage, lipid metabolism may involve neuronal damage and development of DNs as well [19]. Since both pancreas and AT are key tissues involved in age-induced T2D and its complications, this study was designed to investigate whether T2D alters the expression of genes with a function in neuronal processes in human pancreas and AT and that might be implicated in the insurgence of DNs. To investigate whether there are genes with a neuronal function that could show highly and clear changes in expression and that caused by age-induced T2D, we measured mRNA expression in human pancreas and adipose tissue (AT) with T2D. As depicted in Table 1 Table 1 and Figure 1, two genes OLIG1 and BAG3 were highly up-regulated and eight genes PRDM16 , GLDNA , APOA1 , CCKBR , EDN3 , VAV3 , CXCR4 , and GHRL were down regulated in pancreas with T2D as compared to pancreas control. Based on Gene Ontology database search, OLIG1 gene shows functions in neuron fate commitment, neurogenesis, generation of neurons, and neuron differentiation as shown in Figure 2. Based on database search, BAG3 gene showed only a neural function (i.e. neuron part). There were 24 neuron functions found for these 10 genes in pancreas of which chemokine C-X-C receptor (CXCR4) gene was shown to have a role in 17 neural functions based on Gene Ontology database (Figure 2). (Figure 2). Among eight down-regulated genes in pancreas with T2D, VAV3 gene was highest down-regulated gene with approximately 246-fold (Table 1 and Figure 1). The expression of 15 genes were found to be highly altered in AT caused by age-induced T2D (Table 2 and Figure 3). From these 15 genes, 8 gens were highly up- regulated and 7 genes highly down-regulated (Table 2, and Figure 3). The expression of synaptotagmin-4 ( SYT4 ) gene were tremendously high up-regulated (approximately 392-fold) in AT-T2D as compared to AT-control, while VGF (neurosecretory protein) is highly down-regulated (approximately 119-fold) Table 2 and Figure 3). Another gene, which is very highly up-regulated in AT-T2D as compared to AT-control was MYRF (Myelin regulatory factor) as displayed in Table 2 and Figure 3. The fold changes of all 15 genes were reported in Table 2. Based on g ene o ntology database search, 52 neural functions were found for these 15 genes (Figure 4). (Figure 4). Although VGF gene was highly down-regulated, only one neural function (i.e. neuropeptide hormone activity) was shown to be linked with this gene (Figure 4). SYT4 gene showed a link with 5 neural functions; 1- neurological system process, 2- neurotransmitter secretion, 3- neurotransmitter transport 4- neuron part and 5- neuron projection. Based on Gene Ontology search, PTN and LRNN4 genes showed only link with one neural function (Figure 4) and both genes were up-regulated, while the other genes showed multiple neural functions. The in-silico functional analysis conducted on the list of 25 genes, led to the identification of several molecule-function/disease connections, as shown in Figure 5. Focusing on SYT4 , VGF , BAG3 , APOA1 , and VAV3 and on their tightly related interactors, which in turn participated to lipid metabolism, insulin, protein kinase C (PKC), advanced glycation end (AGE) products and MAPK signaling pathways, as well as to the electron transport chain, oxidative stress and glucose metabolism biological processes, we have drawn a global interaction network (Figure 6). It contained 198 (13.8%) multi- process genes, with 31 ( AKT2, CALM1, CALM2, ...

Similar publications

Article
Full-text available
Background Diabetic peripheral neuropathy (DPN) constitutes a debilitating complication associated with diabetes. Although, the past decade has seen rapid developments in understanding the complex etiology of DPN, there are no approved therapies that can halt the development of DPN, or target the damaged nerve. Therefore, clarifying the pathogenesi...

Citations

... In recent years, SYT4 has attracted much attention as a new intervention target in diabetes-related diseases [52,53]. However, the mechanism regulating SYT4 expression has not yet been determined. ...
... We hypothesized that MYT1 inhibits SYT4 expression via a similar mechanism in ARPE-19 cells. Furthermore, different cell types use different signals to activate SYT4 expression [52]. Therefore, further identification of the unknown factors and mechanisms controlling SYT4 expression is needed to fully understand SYT4-mediated stimulus-secretion coupling in DR. ...
Article
Full-text available
BACKGROUND Synaptotagmins (SYTs) are a family of 17 membrane transporters that function as calcium ion sensors during the release of Ca²⁺-dependent neurotransmitters and hormones. However, few studies have reported whether members of the SYT family play a role in glucose uptake in diabetic retinopathy (DR) through Ca²⁺/glucose transporter-1 (GLUT1) and the possible regulatory mechanism of SYTs. AIM To elucidate the role of the SYT family in the regulation of glucose transport in retinal pigment epithelial cells and explore its potential as a therapeutic target for the clinical management of DR. METHODS DR was induced by streptozotocin in C57BL/6J mice and by high glucose medium in human retinal pigment epithelial cells (ARPE-19). Bioinformatics analysis, reverse transcriptase-polymerase chain reaction, Western blot, flow cytometry, ELISA, HE staining, and TUNEL staining were used for analysis. RESULTS Six differentially expressed proteins (SYT2, SYT3, SYT4, SYT7, SYT11, and SYT13) were found between the DR and control groups, and SYT4 was highly expressed. Hyperglycemia induces SYT4 overexpression, manipulates Ca²⁺ influx to induce GLUT1 fusion with the plasma membrane, promotes abnormal expression of the glucose transporter GLUT1 and excessive glucose uptake, induces ARPE-19 cell apoptosis, and promotes DR progression. Parkin deficiency inhibits the proteasomal degradation of SYT4 in DR, resulting in SYT4 accumulation and enhanced GLUT1 fusion with the plasma membrane, and these effects were blocked by oe-Parkin treatment. Moreover, dysregulation of the myelin transcription factor 1 (Myt1)-induced transcription of SYT4 in DR further activated the SYT4-mediated stimulus-secretion coupling process, and this process was inhibited in the oe-MYT1-treated group. CONCLUSION Our study reveals the key role of SYT4 in regulating glucose transport in retinal pigment epithelial cells during the pathogenesis of DR and the underlying mechanism and suggests potential therapeutic targets for clinical DR.
... On the other hand, the functional relevance of the 70 well-characterized genes (shown in Figure 4) extracted some interesting functional blocks. First, the genes associated with the neuronal system were consistent with the fact the brain signaling system is commonly involved before and during the pathogenesis of T2D [46][47][48]. Notable among these are the ADCY5, SLC30A8 and SLC24A3 genes that are involved in neurohormonal transport and solute (especially sodium, calcium and zinc) transport. In addition, the gene coding type 2 ryanodine receptor (RYR2) regulates calcium release in the endoplasmic reticulum of the pancreatic beta cells and is thus known to be involved in insulin secretion and glycemic homeostasis [49]. ...
Article
Full-text available
Type 2 diabetes (T2D) is a complex metabolic derangement that has a strong genetic basis. There is substantial population-specificity in the association of genetic variants with T2D. The Indian urban Sindhi population is at a high risk of T2D. The genetic basis of T2D in this population is unknown. We interrogated 28 pooled whole blood genomes of 1402 participants from the Diabetes In Sindhi Families In Nagpur (DISFIN) study using Illumina’s Global Screening Array. From a total of 608,550 biallelic variants, 140 were significantly associated with T2D after adjusting for comorbidities, batch effects, pooling error, kinship status and pooling variation in a random effects multivariable logistic regression framework. Of the 102 well-characterized genes that these variants mapped onto, 70 genes have been previously reported to be associated with T2D to varying degrees with known functional relevance. Excluding open reading frames, intergenic non-coding elements and pseudogenes, our study identified 22 novel candidate genes in the Sindhi population studied. Our study thus points to the potential, interesting candidate genes associated with T2D in an ethnically endogamous population. These candidate genes need to be fully investigated in future studies.
... The upregulation of SYT4 inhibits the release of oxytocin, which is a characteristic in obese phenotype (Tong, 2011;Zhang et al., 2011). The negative regulation of SYT4 could potentially repair or reduce the degree of diabetes neuropathies (Rahimi et al., 2015); however, the physiological function of SYT4 remains unknown. A specific mouse model showed that SYT4 upregulation, within dystrophic neurons, could reflect impaired protein degradation that happens in AD (Zhang et al., 2009), suggesting its implication in this disease. ...
Article
Full-text available
Obesity is a multifactorial disease in which environmental conditions and several genes play an important role in the development of this disease. Obesity is associated with neurodegenerative diseases (Alzheimer, Parkinson, and Huntington diseases) and with neurodevelopmental diseases (autism disorder, schizophrenia, and fragile X syndrome). Some of the environmental conditions that lead to obesity are physical activity, alcohol consumption, socioeconomic status, parent feeding behavior, and diet. Interestingly, some of these environmental conditions are shared with neurodegenerative and neurodevelopmental diseases. Obesity impairs neurodevelopment abilities as memory and fine-motor skills. Moreover, maternal obesity affects the cognitive function and mental health of the offspring. The common biological mechanisms involved in obesity and neurodegenerative/neurodevelopmental diseases are insulin resistance, pro-inflammatory cytokines, and oxidative damage, among others, leading to impaired brain development or cell death. Obesogenic environmental conditions are not the only factors that influence neurodegenerative and neurodevelopmental diseases. In fact, several genes implicated in the leptin–melanocortin pathway (LEP, LEPR, POMC, BDNF, MC4R, PCSK1, SIM1, BDNF, TrkB, etc.) are associated with obesity and neurodegenerative and neurodevelopmental diseases. Moreover, in the last decades, the discovery of new genes associated with obesity (FTO, NRXN3, NPC1, NEGR1, MTCH2, GNPDA2, among others) and with neurodegenerative or neurodevelopmental diseases (APOE, CD38, SIRT1, TNFα, PAI-1, TREM2, SYT4, FMR1, TET3, among others) had opened new pathways to comprehend the common mechanisms involved in these diseases. In conclusion, the obesogenic environmental conditions, the genes, and the interaction gene–environment would lead to a better understanding of the etiology of these diseases.
... Obesity is associated with chronic activation of low-grade inflammation [3], which is implicated in the pathogenesis of obesity-associated diseases including insulin resistance, type-2 diabetes (T2D) [4,5] and cardiovascular disease [6,7]. The etiology of obesity and low-grade inflammation is complex and involves intrinsic and extrinsic factors. ...
... These all promoted us to investigate the effect of PA on inflammation in human SAT, lipogenesis and glucose uptake. Accumulating evidence shows that AT is considered as one of the major sites of low grade inflammation in obese subjects [23][24][25], which contributes to obesity associated energy metabolic disorders such as type 2 diabetes (T2D) and cardiovascular diseases (CVDs) [4][5][6][7]. In the present study we have shown that PA inhibits the secretion of certain proinflammatory markers in human SAT. ...
Article
Full-text available
Adipose tissue is a primary site of obesity-induced inflammation, which has been emerging as an important contributor to obesity associated disorders. The factors influencing adipose tissue-induced inflammation and the resulting pathophysiological events remain poorly understood. However, dietary fiber consumptions appear to be protective. Short-chain fatty acids such as propionic acid (PA) are the principal products of the dietary fiber fermentation by microbiota. Therefore, we aim to investigate the influence of PA on inflammation, lipogenesis and glucose uptake markers from human subcutaneous adipose tissue (SAT). We showed that the treatment of SAT with PA resulted in a significant downregulation of inflammatory parameters (e.g. TNF-α and IP-10) and macrophage markers (e.g. CD163 and MMP-9). The expression levels of PA receptors (i.e. G protein coupled receptor-41 and -43) in human primary adipocytes were very low in comparison with SAT and macrophages. Upon PA treatment, no anti-inflammatory effect was observed in human adipocytes. PA significantly upregulated the expression of lipoprotein lipase (LPL), sterol regulatory-element-binding protein-1c (SREBP-1c) and glucose transporter 4 (GLUT-4), which are associated with lipogenesis and glucose uptake. We also showed that the observed anti-inflammatory effects of PA on SAT were partly mediated by Gi/o protein coupled receptor. Our data suggests that PA anti-inflammatory effects on SAT are mediated partly via Gi/o proteins, leading to the improved expression of factors associated with lipogenesis and glucose uptake. These responses appeared to be not mediated by adipocytes; but most probably by macrophages. The current study provides new knowledge, which can be used as a potential new avenue for drug development in preventing obesity-related inflammation and metabolic disorders in future.
... Obesity is associated with chronic activation of low-grade inflammation [3], which is implicated in the pathogenesis of obesity-associated diseases including insulin resistance, type-2 diabetes (T2D) [4,5] and cardiovascular disease [6,7]. The etiology of obesity and low-grade inflammation is complex and involves intrinsic and extrinsic factors. ...
... These all promoted us to investigate the effect of PA on inflammation in human SAT, lipogenesis and glucose uptake. Accumulating evidence shows that AT is considered as one of the major sites of low grade inflammation in obese subjects [23][24][25], which contributes to obesity associated energy metabolic disorders such as type 2 diabetes (T2D) and cardiovascular diseases (CVDs) [4][5][6][7]. In the present study we have shown that PA inhibits the secretion of certain proinflammatory markers in human SAT. ...
Article
Full-text available
Background: Antibiotic resistant strains of Pseudomonas aeruginosa are the cause of Gram negative nosocomial infections especially among the immunosuppressed patients. The bacteria contains las I and las R genes that play very important roles in the pathogenesis and mechanisms of aggression. These genes can be influenced by the quorum sensing (QS) system and such mechanism is becoming clinically important worldwide. This study aimed to investigate the preventive effects of green coffee extract (GCE) on the expression of pathogenesis-related genes, las I and las R in P. aeruginosa. Methods: A total of fifty four P. aeruginosa strains were isolated out of 100 clinical samples collected from the infectious wards in different hospitals (Tehran province) using conventional microscopic and biochemical methods. Susceptibility of the isolates to different antibiotics, GCE and chlorogenic acid were elucidated. Multiplex polymerase chain reaction (PCR) and real-time PCR were performed to detect and quantify the expression levels of las I and las R genes. The presence of chlorogenic acid in GCE was confirmed by HPLC. Results: Antibiotic susceptibility tests revealed multidrug resistance among the clinical isolates of those 40 strains were resistant to ciprofloxacin (74.07%), 43 to ceftazidime (79.26%), 29 to amikacin (53.7%), 42 to ampicillin (77.77%), 17 to colistin (31.48%), 40 to gentamicin (74.77%), and 50 to piperacillin (92.59%). PCR outcomes exhibited that the frequency of las I and las R genes were 100% in resistant and sensitive strains isolated from clinical and standard strains of P. aeruginosa (ATCC 15449). Real-time PCR analyses revealed that GCE significantly prevented the expression of las I and las R genes in P. aeruginosa. GCE at concentration level as low as 2.5 mg/mL could prevent the expression of lasI and lasR genes in P. aeruginosa clinical isolates. Conclusion: The presence and expression levels of las I and las R genes in P. aeruginosa isolates were investigated when the bacteria was exposed to GCE. Our results tend to suggest that genes involved in pathogenesis of:Pseudomonas aeruginosa are down regulated by quorum sensing effect of chlorogenic acid and therefore GCE could be useful as an adjuvant in combating multidrug resistance strains of Pseudomonas aeruginosa.
... We suggest that this SNP may affect the metformin-mediated glucose uptake through AMPK. In addition, as VAV3 is down-regulated in human pancreas with type 2 diabetes compared to healthy pancreas, this polymorphic variant of VAV3 may contribute to less severe diabetic neurophaties 36 . The SNP V594M VAV2 rs602990 is located in the first SH3 domain. ...
Article
Full-text available
Hypertension, diabetes and obesity are cardiovascular risk factors closely associated to the development of renal and cardiovascular target organ damage. VAV2 and VAV3, members of the VAV family proto-oncogenes, are guanosine nucleotide exchange factors for the Rho and Rac GTPase family, which is related with cardiovascular homeostasis. We have analyzed the relationship between the presence of VAV2 rs602990 and VAV3 rs7528153 polymorphisms with cardiovascular risk factors and target organ damage (heart, vessels and kidney) in 411 subjects. Our results show that being carrier of the T allele in VAV2 rs602990 polymorphism is associated with an increased risk of obesity, reduced levels of ankle-brachial index and diastolic blood pressure and reduced retinal artery caliber. In addition, being carrier of T allele is associated with increased risk of target organ damage in males. On the other hand, being carrier of the T allele in VAV3 rs7528153 polymorphism is associated with a decreased susceptibility of developing a pathologic state composed by the presence of hypertension, diabetes, obesity or cardiovascular damage, and with an increased risk of developing altered basal glycaemia. This is the first report showing an association between VAV2 and VAV3 polymorphisms with cardiovascular risk factors and target organ damage.
... The current standard therapy for T2DM is medical treatment which cornerstone is intensive lifestyle modification strategies [3]. However, only partially patients achieve adequate glycemic control and a reduction in cardiovascular risk [4][5][6]. ...
Article
Full-text available
Background: To compare short-term and long-term results of bariatric surgery vs non-surgical treatment for type 2 diabetes mellitus (T2DM). Methods: A systematic search was conducted in the PubMed, Embase, and Cochrane Library databases for randomized controlled trials (RCTs). All statistical analysis was performed using Review Manager version 5.3. The dichotomous data was calculated using risk ratio (RR) and continuous data was using mean differences (MD) along with 95% confidence intervals (CI). Results: A total of 8 RCTs with 619 T2DM patients were analyzed. Compared with non-surgical treatment group, bariatric surgery group was associated with higher rate T2DM remission (RR = 5.76, 95%CI:3.15-10.55, P < 0.00001), more reduction HbA1C (MD = 1.29, 95%CI: -1.70 to -0.87, P < 0.00001), more decrease fasting plasma glucose (MD = -36.38, 95%CI: -51.76 to -21.01, P < 0.00001), greater loss body weight (MD = -16.93, 95%CI: 19.78 to -14.08, P < 0.00001), more reduction body mass index (MD = -5.80, 95%CI: -6.95 to -4.64, P < 0.00001), more decrease triglyceride concentrations (MD = -51.27, 95%CI: -74.13 to -28.41, P < 0.0001), and higher increase density lipoprotein cholesterol (MD = 9.10, 95%CI: 7.99 to 10.21; P < 0.00001). But total and low density lipoprotein cholesterol were no significant changes. Conclusion: Bariatric surgery for T2DM is efficacious and improves short- and long-term outcomes as compared with non-surgical treatment.
Article
Neuroendocrine regulatory polypeptide VGF (nerve growth factor inducible) was firstly found in the rapid induction of nerve growth factor on PC12 cells. It was selectively distributed in neurons and many neuroendocrine tissues. This paper reviewed the latest literatures on the gene structure, transcriptional regulation, protein processing, distribution and potential receptors of VGF. The neuroendocrine roles of VGF and its derived polypeptides in regulating energy, water electrolyte balance, circadian rhythm and reproductive activities were also summarized. Furthermore, based on the experimental evidence in vivo and in vitro, dysregulation of VGF in different neuroendocrine diseases and the possible mechanism mediated by VGF polypeptides were discussed. We next discussed the potential as the clinical diagnosis and therapy for VGF related diseases in the future.
Article
Obesity is an indication of an imbalance between energy expenditure and food intake. It is a complicated disease of epidemic proportions as it involves many factors and organs. Sedentary lifestyles and overeating have caused a substantial rise in people with obesity and type 2 diabetes. Thus, the discovery of successful and sustainable therapies for these chronic illnesses is critical. However, the mechanisms of obesity and diabetes and the crosstalk between these diseases are still ambiguous. Numerous studies are being done to study these mechanisms, with updates made frequently. VGF peptide and its derivatives are anticipated to have a role in the development of obesity and diabetes. However, contradictory studies have produced conflicting findings on the function of VGF. Therefore, in this review, we attempt to clarify and explain the role of VGF peptides in the brain, pancreas, and adipose tissue in the development of obesity.